nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP4F2—mouth—Crohn's disease	0.0342	0.108	CbGeAlD
Fingolimod—Lymphoproliferative disorder—Azathioprine—Crohn's disease	0.0281	0.108	CcSEcCtD
Fingolimod—Varicella—Azathioprine—Crohn's disease	0.0281	0.108	CcSEcCtD
Fingolimod—X-linked lymphoproliferative syndrome—Azathioprine—Crohn's disease	0.0281	0.108	CcSEcCtD
Fingolimod—S1PR5—skin of body—Crohn's disease	0.0202	0.0637	CbGeAlD
Fingolimod—S1PR4—lymphoid tissue—Crohn's disease	0.0195	0.0614	CbGeAlD
Fingolimod—CYP4F2—mammalian vulva—Crohn's disease	0.0173	0.0544	CbGeAlD
Fingolimod—S1PR3—smooth muscle tissue—Crohn's disease	0.017	0.0536	CbGeAlD
Fingolimod—S1PR5—lymphoid tissue—Crohn's disease	0.0163	0.0515	CbGeAlD
Fingolimod—S1PR1—epithelium—Crohn's disease	0.0156	0.049	CbGeAlD
Fingolimod—CYP4F2—digestive system—Crohn's disease	0.0151	0.0477	CbGeAlD
Fingolimod—S1PR1—smooth muscle tissue—Crohn's disease	0.015	0.0473	CbGeAlD
Fingolimod—SPHK1—smooth muscle tissue—Crohn's disease	0.0148	0.0467	CbGeAlD
Fingolimod—SPHK1—skin of body—Crohn's disease	0.0146	0.0461	CbGeAlD
Fingolimod—S1PR3—lymphoid tissue—Crohn's disease	0.0136	0.0428	CbGeAlD
Fingolimod—SPHK1—mammalian vulva—Crohn's disease	0.0133	0.0421	CbGeAlD
Fingolimod—CYP4F12—mammalian vulva—Crohn's disease	0.0128	0.0404	CbGeAlD
Fingolimod—S1PR1—lymphoid tissue—Crohn's disease	0.012	0.0378	CbGeAlD
Fingolimod—CYP4F12—digestive system—Crohn's disease	0.0112	0.0355	CbGeAlD
Fingolimod—S1PR4—lymph node—Crohn's disease	0.011	0.0346	CbGeAlD
Fingolimod—Lymphoma—Azathioprine—Crohn's disease	0.0109	0.0419	CcSEcCtD
Fingolimod—Non-Hodgkin's lymphoma—Azathioprine—Crohn's disease	0.0109	0.0419	CcSEcCtD
Fingolimod—S1PR5—lymph node—Crohn's disease	0.00922	0.0291	CbGeAlD
Fingolimod—S1PR3—lymph node—Crohn's disease	0.00767	0.0242	CbGeAlD
Fingolimod—Liver injury—Mercaptopurine—Crohn's disease	0.00759	0.0292	CcSEcCtD
Fingolimod—S1PR1—lymph node—Crohn's disease	0.00676	0.0213	CbGeAlD
Fingolimod—SPHK1—lymph node—Crohn's disease	0.00669	0.0211	CbGeAlD
Fingolimod—CYP4F12—lymph node—Crohn's disease	0.00642	0.0203	CbGeAlD
Fingolimod—SPHK1—Betamethasone—Prednisone—Crohn's disease	0.00561	0.5	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Prednisone—Crohn's disease	0.00561	0.5	CbGdCrCtD
Fingolimod—Herpes zoster—Azathioprine—Crohn's disease	0.00505	0.0194	CcSEcCtD
Fingolimod—Liver injury—Azathioprine—Crohn's disease	0.00452	0.0174	CcSEcCtD
Fingolimod—Gamma-glutamyltransferase increased—Mesalazine—Crohn's disease	0.00421	0.0162	CcSEcCtD
Fingolimod—Liver injury—Mesalazine—Crohn's disease	0.00412	0.0158	CcSEcCtD
Fingolimod—Hepatic enzyme increased—Mesalazine—Crohn's disease	0.00366	0.0141	CcSEcCtD
Fingolimod—Lymphopenia—Prednisone—Crohn's disease	0.00358	0.0138	CcSEcCtD
Fingolimod—Gastroenteritis—Mesalazine—Crohn's disease	0.00284	0.0109	CcSEcCtD
Fingolimod—Alopecia—Mercaptopurine—Crohn's disease	0.00283	0.0109	CcSEcCtD
Fingolimod—Eczema—Mesalazine—Crohn's disease	0.0028	0.0108	CcSEcCtD
Fingolimod—Blood triglycerides increased—Prednisone—Crohn's disease	0.0028	0.0108	CcSEcCtD
Fingolimod—Eye pain—Mesalazine—Crohn's disease	0.00279	0.0107	CcSEcCtD
Fingolimod—Leukopenia—Mercaptopurine—Crohn's disease	0.0025	0.0096	CcSEcCtD
Fingolimod—Migraine—Mesalazine—Crohn's disease	0.00248	0.00952	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00236	0.00907	CcSEcCtD
Fingolimod—Liver function test abnormal—Mesalazine—Crohn's disease	0.00232	0.00893	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00227	0.00871	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00222	0.00853	CcSEcCtD
Fingolimod—Skin disorder—Mercaptopurine—Crohn's disease	0.00221	0.00851	CcSEcCtD
Fingolimod—Influenza—Mesalazine—Crohn's disease	0.00217	0.00836	CcSEcCtD
Fingolimod—Pneumonia—Azathioprine—Crohn's disease	0.00214	0.00823	CcSEcCtD
Fingolimod—Infestation—Azathioprine—Crohn's disease	0.00213	0.00818	CcSEcCtD
Fingolimod—Infestation NOS—Azathioprine—Crohn's disease	0.00213	0.00818	CcSEcCtD
Fingolimod—Bronchitis—Mesalazine—Crohn's disease	0.00209	0.00804	CcSEcCtD
Fingolimod—Weight decreased—Mesalazine—Crohn's disease	0.00197	0.00756	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00197	0.00756	CcSEcCtD
Fingolimod—Pneumonia—Mesalazine—Crohn's disease	0.00195	0.00749	CcSEcCtD
Fingolimod—Infestation—Mesalazine—Crohn's disease	0.00194	0.00745	CcSEcCtD
Fingolimod—Infestation NOS—Mesalazine—Crohn's disease	0.00194	0.00745	CcSEcCtD
Fingolimod—Depression—Mesalazine—Crohn's disease	0.00193	0.00743	CcSEcCtD
Fingolimod—CYP2E1—lymphoid tissue—Crohn's disease	0.00192	0.00605	CbGeAlD
Fingolimod—CYP2E1—digestive system—Crohn's disease	0.0019	0.00598	CbGeAlD
Fingolimod—Sinusitis—Mesalazine—Crohn's disease	0.00182	0.00699	CcSEcCtD
Fingolimod—Mediastinal disorder—Azathioprine—Crohn's disease	0.00172	0.00662	CcSEcCtD
Fingolimod—Connective tissue disorder—Mesalazine—Crohn's disease	0.00171	0.00657	CcSEcCtD
Fingolimod—Alopecia—Azathioprine—Crohn's disease	0.00169	0.00649	CcSEcCtD
Fingolimod—Eye disorder—Mesalazine—Crohn's disease	0.00163	0.00625	CcSEcCtD
Fingolimod—Cardiac disorder—Mesalazine—Crohn's disease	0.00162	0.00621	CcSEcCtD
Fingolimod—Angiopathy—Mesalazine—Crohn's disease	0.00158	0.00607	CcSEcCtD
Fingolimod—Mediastinal disorder—Mesalazine—Crohn's disease	0.00157	0.00603	CcSEcCtD
Fingolimod—Diarrhoea—Mercaptopurine—Crohn's disease	0.00156	0.00599	CcSEcCtD
Fingolimod—Alopecia—Mesalazine—Crohn's disease	0.00154	0.00591	CcSEcCtD
Fingolimod—CYP3A4—digestive system—Crohn's disease	0.00153	0.00481	CbGeAlD
Fingolimod—Mental disorder—Mesalazine—Crohn's disease	0.00153	0.00586	CcSEcCtD
Fingolimod—CYP2D6—digestive system—Crohn's disease	0.0015	0.00474	CbGeAlD
Fingolimod—Leukopenia—Azathioprine—Crohn's disease	0.00149	0.00572	CcSEcCtD
Fingolimod—Back pain—Mesalazine—Crohn's disease	0.00147	0.00563	CcSEcCtD
Fingolimod—Vision blurred—Mesalazine—Crohn's disease	0.00143	0.00549	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00141	0.00541	CcSEcCtD
Fingolimod—Leukopenia—Mesalazine—Crohn's disease	0.00136	0.00521	CcSEcCtD
Fingolimod—Infection—Azathioprine—Crohn's disease	0.00135	0.00518	CcSEcCtD
Fingolimod—Palpitations—Mesalazine—Crohn's disease	0.00134	0.00515	CcSEcCtD
Fingolimod—Cough—Mesalazine—Crohn's disease	0.00132	0.00508	CcSEcCtD
Fingolimod—Skin disorder—Azathioprine—Crohn's disease	0.00132	0.00507	CcSEcCtD
Fingolimod—Hypertension—Mesalazine—Crohn's disease	0.00131	0.00503	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00128	0.00492	CcSEcCtD
Fingolimod—Hypotension—Azathioprine—Crohn's disease	0.00127	0.00488	CcSEcCtD
Fingolimod—Cardiac arrest—Prednisone—Crohn's disease	0.00127	0.00486	CcSEcCtD
Fingolimod—Infection—Mesalazine—Crohn's disease	0.00123	0.00472	CcSEcCtD
Fingolimod—Nervous system disorder—Mesalazine—Crohn's disease	0.00121	0.00466	CcSEcCtD
Fingolimod—Skin disorder—Mesalazine—Crohn's disease	0.0012	0.00462	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00117	0.00451	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00117	0.0045	CcSEcCtD
Fingolimod—Hypotension—Mesalazine—Crohn's disease	0.00116	0.00444	CcSEcCtD
Fingolimod—Paraesthesia—Mesalazine—Crohn's disease	0.00111	0.00427	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—PLA2G4F—Crohn's disease	0.0011	0.00269	CbGpPWpGaD
Fingolimod—Dyspnoea—Mesalazine—Crohn's disease	0.0011	0.00424	CcSEcCtD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—JAK2—Crohn's disease	0.0011	0.00267	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CCR9—Crohn's disease	0.00109	0.00266	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CCR9—Crohn's disease	0.00109	0.00266	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CCR9—Crohn's disease	0.00109	0.00266	CbGpPWpGaD
Fingolimod—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00107	0.0041	CcSEcCtD
Fingolimod—Fatigue—Mesalazine—Crohn's disease	0.00107	0.0041	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—GPR65—Crohn's disease	0.00106	0.00257	CbGpPWpGaD
Fingolimod—Weight decreased—Prednisone—Crohn's disease	0.00104	0.004	CcSEcCtD
Fingolimod—Depression—Prednisone—Crohn's disease	0.00102	0.00393	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—ACKR2—Crohn's disease	0.00102	0.00248	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—GPR65—Crohn's disease	0.00102	0.00247	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—GPR65—Crohn's disease	0.00102	0.00247	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—GPR65—Crohn's disease	0.00102	0.00247	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CCR9—Crohn's disease	0.000993	0.00241	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ACKR2—Crohn's disease	0.000983	0.00239	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ACKR2—Crohn's disease	0.000983	0.00239	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MLN—Crohn's disease	0.000968	0.00235	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PLA2G4F—Crohn's disease	0.000954	0.00232	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—MTMR3—Crohn's disease	0.00094	0.00228	CbGpPWpGaD
Fingolimod—Bradycardia—Prednisone—Crohn's disease	0.000938	0.0036	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—MLN—Crohn's disease	0.000932	0.00227	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MLN—Crohn's disease	0.000932	0.00227	CbGpPWpGaD
Fingolimod—Diarrhoea—Azathioprine—Crohn's disease	0.000929	0.00357	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—GPR65—Crohn's disease	0.000923	0.00224	CbGpPWpGaD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—STAT3—Crohn's disease	0.000909	0.00221	CbGpPWpGaD
Fingolimod—Connective tissue disorder—Prednisone—Crohn's disease	0.000905	0.00348	CcSEcCtD
Fingolimod—Dizziness—Azathioprine—Crohn's disease	0.000898	0.00345	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—ACKR2—Crohn's disease	0.000893	0.00217	CbGpPWpGaD
Fingolimod—Asthenia—Mesalazine—Crohn's disease	0.000887	0.00341	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—TAGAP—Crohn's disease	0.000886	0.00215	CbGpPWpGaD
Fingolimod—Pruritus—Mesalazine—Crohn's disease	0.000875	0.00336	CcSEcCtD
Fingolimod—Eye disorder—Prednisone—Crohn's disease	0.000861	0.00331	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—TAGAP—Crohn's disease	0.000853	0.00207	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TAGAP—Crohn's disease	0.000853	0.00207	CbGpPWpGaD
Fingolimod—Headache—Azathioprine—Crohn's disease	0.000851	0.00327	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—MLN—Crohn's disease	0.000847	0.00206	CbGpPWpGaD
Fingolimod—Diarrhoea—Mesalazine—Crohn's disease	0.000846	0.00325	CcSEcCtD
Fingolimod—Angiopathy—Prednisone—Crohn's disease	0.000836	0.00321	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—CCR6—Crohn's disease	0.000829	0.00201	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PLA2G4F—Crohn's disease	0.000819	0.00199	CbGpPWpGaD
Fingolimod—Dizziness—Mesalazine—Crohn's disease	0.000818	0.00314	CcSEcCtD
Fingolimod—Alopecia—Prednisone—Crohn's disease	0.000814	0.00313	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—MTMR3—Crohn's disease	0.000811	0.00197	CbGpPWpGaD
Fingolimod—Mental disorder—Prednisone—Crohn's disease	0.000807	0.0031	CcSEcCtD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—STAT3—Crohn's disease	0.000805	0.00196	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CCR6—Crohn's disease	0.000798	0.00194	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CCR6—Crohn's disease	0.000798	0.00194	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ACKR2—Crohn's disease	0.00079	0.00192	CbGpPWpGaD
Fingolimod—S1PR4—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000781	0.0019	CbGpPWpGaD
Fingolimod—Headache—Mesalazine—Crohn's disease	0.000775	0.00298	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—TAGAP—Crohn's disease	0.000774	0.00188	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—RSPO3—Crohn's disease	0.000774	0.00188	CbGpPWpGaD
Fingolimod—Vision blurred—Prednisone—Crohn's disease	0.000756	0.0029	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—CCR6—Crohn's disease	0.000753	0.00183	CbGpPWpGaD
Fingolimod—S1PR5—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000751	0.00183	CbGpPWpGaD
Fingolimod—S1PR3—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000751	0.00183	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MLN—Crohn's disease	0.000749	0.00182	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—RSPO3—Crohn's disease	0.000745	0.00181	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—RSPO3—Crohn's disease	0.000745	0.00181	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SEL1L—Crohn's disease	0.000734	0.00178	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—FADS1—Crohn's disease	0.000732	0.00178	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—PTGER4—Crohn's disease	0.00073	0.00177	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CCR6—Crohn's disease	0.000725	0.00176	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CCR6—Crohn's disease	0.000725	0.00176	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CCR6—Crohn's disease	0.000725	0.00176	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SEL1L—Crohn's disease	0.000707	0.00172	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SEL1L—Crohn's disease	0.000707	0.00172	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—PTGER4—Crohn's disease	0.000703	0.00171	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—PTGER4—Crohn's disease	0.000703	0.00171	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—MTMR3—Crohn's disease	0.000697	0.00169	CbGpPWpGaD
Fingolimod—Hypertension—Prednisone—Crohn's disease	0.000692	0.00266	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—GPX4—Crohn's disease	0.000685	0.00167	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TAGAP—Crohn's disease	0.000685	0.00167	CbGpPWpGaD
Fingolimod—S1PR1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000682	0.00166	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000678	0.0026	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—RSPO3—Crohn's disease	0.000677	0.00164	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCR9—Crohn's disease	0.000671	0.00163	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—PTGER4—Crohn's disease	0.000663	0.00161	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—GCKR—Crohn's disease	0.000662	0.00161	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CCR6—Crohn's disease	0.000658	0.0016	CbGpPWpGaD
Fingolimod—Infection—Prednisone—Crohn's disease	0.00065	0.0025	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—CCR9—Crohn's disease	0.000646	0.00157	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCR9—Crohn's disease	0.000646	0.00157	CbGpPWpGaD
Fingolimod—Nervous system disorder—Prednisone—Crohn's disease	0.000642	0.00247	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—SEL1L—Crohn's disease	0.000642	0.00156	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—PTGER4—Crohn's disease	0.000638	0.00155	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—PTGER4—Crohn's disease	0.000638	0.00155	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000638	0.00155	CbGpPWpGaD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—IL6—Crohn's disease	0.000637	0.00155	CbGpPWpGaD
Fingolimod—Skin disorder—Prednisone—Crohn's disease	0.000636	0.00244	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—FADS1—Crohn's disease	0.000632	0.00154	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—GPR65—Crohn's disease	0.000624	0.00152	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—IL3—Crohn's disease	0.000622	0.00151	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000621	0.00151	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000601	0.00146	CbGpPWpGaD
Fingolimod—SPHK1—Signaling by VEGF—IL6—Crohn's disease	0.000601	0.00146	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—GPR65—Crohn's disease	0.000601	0.00146	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—GPR65—Crohn's disease	0.000601	0.00146	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—RSPO3—Crohn's disease	0.000599	0.00146	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—IL3—Crohn's disease	0.000598	0.00145	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—IL3—Crohn's disease	0.000598	0.00145	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000598	0.00145	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000598	0.00145	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—GPX4—Crohn's disease	0.000592	0.00144	CbGpPWpGaD
Fingolimod—Paraesthesia—Prednisone—Crohn's disease	0.000588	0.00226	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—CCR9—Crohn's disease	0.000587	0.00143	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—PTGER4—Crohn's disease	0.000579	0.00141	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000579	0.00141	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000579	0.00141	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—GCKR—Crohn's disease	0.000571	0.00139	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SEL1L—Crohn's disease	0.000568	0.00138	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—IL3—Crohn's disease	0.000564	0.00137	CbGpPWpGaD
Fingolimod—Fatigue—Prednisone—Crohn's disease	0.000564	0.00217	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—RASGRP1—Crohn's disease	0.000546	0.00133	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—GPR65—Crohn's disease	0.000545	0.00133	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL3—Crohn's disease	0.000543	0.00132	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL3—Crohn's disease	0.000543	0.00132	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—IL3—Crohn's disease	0.000543	0.00132	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—FADS1—Crohn's disease	0.000543	0.00132	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000543	0.00132	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—RASGRP1—Crohn's disease	0.000526	0.00128	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—RASGRP1—Crohn's disease	0.000526	0.00128	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000526	0.00128	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCR9—Crohn's disease	0.000519	0.00126	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—GPX4—Crohn's disease	0.000508	0.00124	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL3—Crohn's disease	0.000493	0.0012	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—GCKR—Crohn's disease	0.000491	0.00119	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—GPR65—Crohn's disease	0.000483	0.00117	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—GPX4—Crohn's disease	0.000481	0.00117	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000477	0.00116	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—CXCL8—Crohn's disease	0.000473	0.00115	CbGpPWpGaD
Fingolimod—Asthenia—Prednisone—Crohn's disease	0.000469	0.0018	CcSEcCtD
Fingolimod—Pruritus—Prednisone—Crohn's disease	0.000463	0.00178	CcSEcCtD
Fingolimod—S1PR5—GPCR ligand binding—CXCL8—Crohn's disease	0.000455	0.00111	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—CXCL8—Crohn's disease	0.000455	0.00111	CbGpPWpGaD
Fingolimod—Diarrhoea—Prednisone—Crohn's disease	0.000448	0.00172	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—CCR6—Crohn's disease	0.000445	0.00108	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—IL2RA—Crohn's disease	0.000435	0.00106	CbGpPWpGaD
Fingolimod—Dizziness—Prednisone—Crohn's disease	0.000433	0.00166	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—CCR6—Crohn's disease	0.000428	0.00104	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCR6—Crohn's disease	0.000428	0.00104	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—IL2RA—Crohn's disease	0.000419	0.00102	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—IL2RA—Crohn's disease	0.000419	0.00102	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—CXCL8—Crohn's disease	0.000413	0.001	CbGpPWpGaD
Fingolimod—Headache—Prednisone—Crohn's disease	0.00041	0.00158	CcSEcCtD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000408	0.000993	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—RBX1—Crohn's disease	0.000402	0.000978	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—IL2RA—Crohn's disease	0.000395	0.000961	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PTGER4—Crohn's disease	0.000391	0.000952	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCR6—Crohn's disease	0.000389	0.000945	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—RBX1—Crohn's disease	0.000387	0.000941	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—RBX1—Crohn's disease	0.000387	0.000941	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL2RA—Crohn's disease	0.000381	0.000925	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL2RA—Crohn's disease	0.000381	0.000925	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000381	0.000925	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PTGER4—Crohn's disease	0.000377	0.000916	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PTGER4—Crohn's disease	0.000377	0.000916	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000357	0.000868	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—UBE2D1—Crohn's disease	0.000353	0.000857	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—RBX1—Crohn's disease	0.000352	0.000854	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000351	0.000853	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL2RA—Crohn's disease	0.000346	0.00084	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCR6—Crohn's disease	0.000344	0.000836	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PTGER4—Crohn's disease	0.000342	0.000832	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—RIPK2—Crohn's disease	0.000342	0.000831	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	0.000341	0.00083	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—UBE2D1—Crohn's disease	0.000339	0.000825	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—UBE2D1—Crohn's disease	0.000339	0.000825	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL3—Crohn's disease	0.000333	0.000811	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—RIPK2—Crohn's disease	0.000329	0.0008	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—RIPK2—Crohn's disease	0.000329	0.0008	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—RASGRP1—Crohn's disease	0.000323	0.000784	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL3—Crohn's disease	0.000321	0.00078	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL3—Crohn's disease	0.000321	0.00078	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—RBX1—Crohn's disease	0.000311	0.000756	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—RASGRP1—Crohn's disease	0.00031	0.000755	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—RASGRP1—Crohn's disease	0.00031	0.000755	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—UBE2D1—Crohn's disease	0.000308	0.000749	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000307	0.000746	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PTGER4—Crohn's disease	0.000303	0.000736	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—RIPK2—Crohn's disease	0.000299	0.000727	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—JAK2—Crohn's disease	0.000293	0.000711	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SOCS1—Crohn's disease	0.000292	0.00071	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL3—Crohn's disease	0.000291	0.000708	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—RASGRP1—Crohn's disease	0.000282	0.000685	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—JAK2—Crohn's disease	0.000282	0.000685	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—JAK2—Crohn's disease	0.000282	0.000685	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SOCS1—Crohn's disease	0.000281	0.000684	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SOCS1—Crohn's disease	0.000281	0.000684	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—TYK2—Crohn's disease	0.000279	0.000677	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—UBE2D1—Crohn's disease	0.000273	0.000663	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—TYK2—Crohn's disease	0.000268	0.000652	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—TYK2—Crohn's disease	0.000268	0.000652	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—CXCL8—Crohn's disease	0.000267	0.000649	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—JAK2—Crohn's disease	0.000266	0.000646	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—RIPK2—Crohn's disease	0.000265	0.000643	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL3—Crohn's disease	0.000258	0.000627	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—CXCL8—Crohn's disease	0.000257	0.000625	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CXCL8—Crohn's disease	0.000257	0.000625	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CXCL8—Crohn's disease	0.000257	0.000625	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—JAK2—Crohn's disease	0.000256	0.000622	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—JAK2—Crohn's disease	0.000256	0.000622	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—JAK2—Crohn's disease	0.000256	0.000622	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SOCS1—Crohn's disease	0.000255	0.000621	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SMAD3—Crohn's disease	0.000252	0.000613	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—RASGRP1—Crohn's disease	0.000249	0.000606	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—TYK2—Crohn's disease	0.000244	0.000592	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SMAD3—Crohn's disease	0.000243	0.00059	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SMAD3—Crohn's disease	0.000243	0.00059	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CXCL8—Crohn's disease	0.000243	0.00059	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL2RA—Crohn's disease	0.000234	0.000568	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CXCL8—Crohn's disease	0.000234	0.000568	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CXCL8—Crohn's disease	0.000234	0.000568	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000233	0.000568	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—JAK2—Crohn's disease	0.000232	0.000565	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SOCS1—Crohn's disease	0.000226	0.000549	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL2RA—Crohn's disease	0.000225	0.000547	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL2RA—Crohn's disease	0.000225	0.000547	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	0.000223	0.000543	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SMAD3—Crohn's disease	0.000221	0.000536	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CXCL8—Crohn's disease	0.000212	0.000515	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—ALB—Crohn's disease	0.000211	0.000512	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL2RA—Crohn's disease	0.000204	0.000496	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SMAD3—Crohn's disease	0.000195	0.000474	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PTGS2—Crohn's disease	0.000184	0.000448	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—ALB—Crohn's disease	0.000182	0.000442	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL2RA—Crohn's disease	0.000181	0.000439	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TYK2—Crohn's disease	0.000165	0.0004	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PTGS2—Crohn's disease	0.000159	0.000387	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TYK2—Crohn's disease	0.000158	0.000385	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TYK2—Crohn's disease	0.000158	0.000385	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—JAK2—Crohn's disease	0.000157	0.000382	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ALB—Crohn's disease	0.000156	0.00038	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—JAK2—Crohn's disease	0.000151	0.000367	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—JAK2—Crohn's disease	0.000151	0.000367	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TYK2—Crohn's disease	0.000144	0.00035	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CXCL8—Crohn's disease	0.000143	0.000348	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CXCL8—Crohn's disease	0.000138	0.000335	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CXCL8—Crohn's disease	0.000138	0.000335	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—JAK2—Crohn's disease	0.000137	0.000334	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTGS2—Crohn's disease	0.000137	0.000332	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—IL6—Crohn's disease	0.000136	0.000331	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PLA2G4F—Crohn's disease	0.000135	0.000327	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL6—Crohn's disease	0.000131	0.000319	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL6—Crohn's disease	0.000131	0.000319	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TYK2—Crohn's disease	0.000127	0.000309	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CXCL8—Crohn's disease	0.000125	0.000304	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—JAK2—Crohn's disease	0.000121	0.000295	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL6—Crohn's disease	0.000119	0.00029	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—STAT3—Crohn's disease	0.000115	0.00028	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MTMR3—Crohn's disease	0.000114	0.000278	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—STAT3—Crohn's disease	0.000111	0.00027	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—STAT3—Crohn's disease	0.000111	0.00027	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CXCL8—Crohn's disease	0.000111	0.000269	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—STAT3—Crohn's disease	0.000101	0.000245	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	9.55e-05	0.000232	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—STAT3—Crohn's disease	8.91e-05	0.000217	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—FADS1—Crohn's disease	8.91e-05	0.000217	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GPX4—Crohn's disease	8.34e-05	0.000203	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MTMR3—Crohn's disease	8.12e-05	0.000197	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GCKR—Crohn's disease	8.06e-05	0.000196	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL6—Crohn's disease	8.05e-05	0.000196	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL6—Crohn's disease	7.75e-05	0.000188	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL6—Crohn's disease	7.75e-05	0.000188	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL6—Crohn's disease	7.04e-05	0.000171	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—FADS1—Crohn's disease	6.32e-05	0.000154	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	6.24e-05	0.000152	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL6—Crohn's disease	6.23e-05	0.000151	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GPX4—Crohn's disease	5.92e-05	0.000144	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GCKR—Crohn's disease	5.72e-05	0.000139	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MTMR3—Crohn's disease	5.31e-05	0.000129	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—FADS1—Crohn's disease	4.13e-05	0.0001	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GPX4—Crohn's disease	3.87e-05	9.41e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GCKR—Crohn's disease	3.74e-05	9.09e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALB—Crohn's disease	2.56e-05	6.23e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS2—Crohn's disease	2.24e-05	5.45e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALB—Crohn's disease	1.82e-05	4.42e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS2—Crohn's disease	1.59e-05	3.87e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALB—Crohn's disease	1.19e-05	2.89e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.04e-05	2.53e-05	CbGpPWpGaD
